Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography

Atherosclerosis

Volumn 218, Issue 1, 2011, Pages 220-225

  Sourij, Harald ^a   Meinitzer, Andreas ^a   Pilz, Stefan ^a,b   Grammer, Tanja B ^c   Winkelmann, Bernhard R ^d   Boehm, Bernhard O ^e   März, Winfried ^a,c,f  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Cardiology Group Sachsenhausen   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f SYNLAB ACADEMY   (Germany)

Author keywords

Arginine; Endothelial function; Global arginine bioavailability ratio; Mortality

Indexed keywords

ARGININE; CITRULLINE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; ORNITHINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETIC PATIENT; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT REFERRAL; PRIORITY JOURNAL;

AGED; ARGININE; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY; CITRULLINE; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NITRIC OXIDE; ORNITHINE; PROPORTIONAL HAZARDS MODELS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 80052273417     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.04.041     Document Type: Article

References (26)

1. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109. III27-32.
2. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002, 106:653-658.
3. Rajapakse N.W., Mattson D.L. Role of l-arginine in nitric oxide production in health and hypertension. Clin Exp Pharmacol Physiol 2009, 36:249-255.
4. Bai Y., Sun L., Yang T., et al. Increase in fasting vascular endothelial function after short-term oral l-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2009, 89:77-84.
5. Regensteiner J.G., Popylisen S., Bauer T.A., et al. Oral l-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc Med 2003, 8:169-175.
6. Morris C.R., Kato G.J., Poljakovic M., et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005, 294:81-90.
7. Romero M.J, Platt D.H., Tawfik H.E., et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008, 102:95-102.
8. Closs E.I. Expression, regulation and function of carrier proteins for cationic amino acids. Curr Opin Nephrol Hypertens 2002, 11:99-107.
9. Xia Y, Dawson V.L., Dawson T.M., Snyder S.H., Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996, 93:6770-6774.
10. Tang W.H., Wang Z., Cho L., Brennan D.M., Hazen S.L. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol 2009, 53:2061-2067.
11. Winkelmann B.R., Marz W., Boehm B.O., et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 2:S1-73.
12. Moore S, Spackman D.H., Stein W.H. Automatic recording apparatus for use in the chromatography of amino acids. Fed Proc 1958, 17:1107-1115.
13. Teerlink T., Nijveldt R.J., de Jong S., van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002, 303:131-137.
14. Alberti K.G, Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998, 15:539-553.
15. Saely C.H., Drexel H., Sourij H., et al. Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis 2008, 199:317-322.
16. Okyay K., Cengel A., Sahinarslan A., et al. Plasma asymmetric dimethylarginine and l-arginine levels in patients with cardiac syndrome X. Coron Artery Dis 2007, 18:539-544.
17. Morris S.M. Arginine metabolism: boundaries of our knowledge. J Nutr 2007, 137:1602S-1609S.
18. Johnson F.K., Johnson R.A., Durante W., et al. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006, 290:R601-608.
19. Tenu J.P., Lepoivre M., Moali C., et al. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-l-arginine on NO synthase activity in murine macrophages. Nitric Oxide 1999, 3:427-438.
20. Preli R.B., Klein K.P., Herrington D.M. Vascular effects of dietary l-arginine supplementation. Atherosclerosis 2002, 162:1-15.
21. Adams M.R., McCredie R., Jessup W., et al. Oral l-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997, 129:261-269.
22. Maxwell A.J., Zapien M.P., Pearce G.L., MacCallum G., Stone P.H. Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol 2002, 39:37-45.
23. Yin W.H, Chen J.W., Tsai C., et al. l-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr 2005, 24:988-997.
24. Blum A., Hathaway L., Mincemoyer R., et al. Oral l-arginine in patients with coronary artery disease on medical management. Circulation 2000, 101:2160-2164.
25. Lubec B., Hayn M., Kitzmuller E., Vierhapper H., Lubec G. l-Arginine reduces lipid peroxidation in patients with diabetes mellitus. Free Radic Biol Med 1997, 22:355-357.
26. Lucotti P., Monti L., Setola E., et al. Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism 2009, 58:1270-1276.